Navigation Links
Professor Vanessa Hayes awarded for exceptional Africa-related work
Date:7/29/2013

Professor Vanessa Hayes received a Celebration of African Australians Inc Award at Parliament House on Saturday.

The awards recognised "exceptional achievements and remarkable contributions to Australia, Africa and the world through education, science, research, philanthropy, leadership and community engagement by African Australians."

Professor Hayes heads the Human Comparative Genomics Team at Sydney's Garvan Institute of Medical Research, while also holding a position as Professor of Genomic Medicine at the J. Craig Venter Institute in San Diego, California.

Born in Cape Town, South Africa, Hayes made Sydney and Australia home in 2003, becoming a citizen in 2006. She was recognized on Saturday for both her contributions to Africa and Australia.

Hayes made headline news in 2010 when she led the team that generated the first complete personalised human DNA sequences (human genomes) for Africa, namely South African and Nobel Peace Laureate Archbishop Desmond Tutu and !Gubi, a Kalahari Bushman from Namibia, and again in 2011 when she co-led a project to generate the complete genome and facial tumour genome of Australia's Tasmanian devil.

At Garvan, she will be using her understanding of the complexities of the Human Genome to drive research focused on identifying the inherited and acquired genetic events that cause prostate cancer.

Generating not only the first human genome for an Australian researcher, the information gained from the African project provided for the first time a true glimpse into the extent of human diversity within Africa. The African genomes (particularly that of Archbishop Tutu) are providing the framework for disease studies and drug development tailored for Africa.

After completing her PhD in the Netherlands in 1999, Hayes returned to South Africa to head a research team that focused on determining genetic susceptibility to HIV infection and disease progression. She became frustrated, realising that the anti-HIV drugs were completely ineffective for Africans.

"At the time there were over 5 million orphans in Southern Africa as a result of HIV. Drug development was being driven out of the United States and Europe and therefore tailored to the majority population, including a deletion within the CCR5 gene only carried by people of European ancestry. This genetic target was absent in African ancestral South Africans," said Professor Hayes.

"One of the biggest issues with not including all indigenous people in genomics is that medicines tailored towards genomic profiling only target anomalies that can be found in current databases. If there are no African genomes in the database, then Africans are excluded from drug development."

All modern humans shared a common ancestor roughly 200 thousand years ago in Africa. The closer a population resides to our early beginnings, the more diversity is carried in the DNA of that population.

To date Hayes has identified the most diverse human genomes within the Southern African Bushman (Khoesan) peoples. In contrast, Europeans and Asians show the least genomic diversity, having gone through a major 'bottleneck' (population reduction) when leaving Africa some 35,000 to 25,000 years ago.

"We found more genetic diversity between two click-speaking Bushmen, who live 500 km from each other, than between me (a red haired) and someone from China," explained Hayes.

"By sequencing the complete genomes of !Gubi and the Archbishop we were able to add 1.3 million gene variants to the databases that weren't there previously -- simply because people hadn't looked in Africa."

Hayes believes that Africa holds many secrets to understanding human disease that have not been tapped. For example the significant link to prostate cancer and aggressive prostate cancer disease observed in men of African ancestry. "Although the Archbishop has been diagnosed with prostate cancer, our current knowledge was unable to predict his disease status based on his DNA sequence," says Hayes.

Among her current projects, Professor Hayes is studying African men from rural areas with aggressive prostate cancer who, unlike Australian men, have not been impacted by western trends in prostate cancer management. She is using this unique resource as a comparative analysis to better understand both the environmental and genetic factors driving prostate cancer within Australia.


'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-292-958-128
Garvan Institute of Medical Research
Source:Eurekalert

Related biology news :

1. NJIT professor collaborated on new federal report on Deepwater Horizon oil spill
2. Journal highlights Arctic sea ice study by UM professor
3. University of Houston engineering professor awarded grant to study melanoma treatment
4. Indiana University associate professor earns APSs Henry Pickering Bowditch Award
5. IOF Medal of Achievement awarded to Professor Adolfo Diez-Perez
6. Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
7. Pierre Delmas Award presented in Rome to Professor Socrates Papapoulos
8. University of Tennessee professors research shows Gulf of Mexico resilient after spill
9. University of Tennessee professor links massive prehistoric bird extinction to human colonization
10. Developmental biologist Arthur Lander named Donald Bren Professor
11. LSU professor discovers how new corals species form in the ocean
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... , March 29, 2017 "Surging application ... deployed by the government are expected to drive the ... The gesture recognition market is expected to be ... CAGR of 29.63% between 2017 and 2022. The touchless ... billion by 2022, growing at a CAGR of 17.44% ...
(Date:3/29/2017)... ... March 29, 2017 , ... ComplianceOnline, the leading governance, risk and compliance advisory ... Medical Device Summit 2017 venue and speaker lineup. The Summit will take place on ... , The Omni Parker House Hotel, which is located at 60 School Street, Boston, ...
(Date:3/29/2017)... DC (PRWEB) , ... March 29, 2017 , ... ... announced today that it is exhibiting in booth 513 at the Association of ... Washington, DC Downtown Hotel, March 29-31. , CANCERSCAPE unites key stakeholders from ...
(Date:3/29/2017)... GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") announced today ... test for breast cancer, via its Virginia ... a blood-based biomarker test with a sophisticated algorithm to determine ... ... BreastSentry measures the fasting plasma levels of two biomarkers in ...
Breaking Biology Technology: